FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
about
MAP kinase pathways in the yeast Saccharomyces cerevisiaeVac7p, a novel vacuolar protein, is required for normal vacuole inheritance and morphologyAutophagy and neurodegenerationLST8 negatively regulates amino acid biosynthesis as a component of the TOR pathwayTor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast.TOR1 and TOR2 have distinct locations in live cellsTor kinases are in distinct membrane-associated protein complexes in Saccharomyces cerevisiae.A functional variomics tool for discovering drug-resistance genes and drug targets.FKBP12 controls aspartate pathway flux in Saccharomyces cerevisiae to prevent toxic intermediate accumulation.Receptor internalization in yeast requires the Tor2-Rho1 signaling pathway.TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain.Probing the membrane environment of the TOR kinases reveals functional interactions between TORC1, actin, and membrane trafficking in Saccharomyces cerevisiaeAntifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug actionRapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TORInference of protein complex activities from chemical-genetic profile and its applications: predicting drug-target pathwaysCloning and characterization of a 92 kDa soluble phosphatidylinositol 4-kinaseThe TOR signaling cascade regulates gene expression in response to nutrientsGolgi manganese transport is required for rapamycin signaling in Saccharomyces cerevisiae.Target of rapamycin and LST8 proteins associate with membranes from the endoplasmic reticulum in the unicellular green alga Chlamydomonas reinhardtii.Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinasesComponents of Golgi-to-vacuole trafficking are required for nitrogen- and TORC1-responsive regulation of the yeast GATA factors.Phosphatidylinositol 4,5-bisphosphate regulates two steps of homotypic vacuole fusionActin cytoskeleton is required for nuclear accumulation of Gln3 in response to nitrogen limitation but not rapamycin treatment in Saccharomyces cerevisiae.Estimating the size and number of autophagic bodies by electron microscopyCell-free reconstitution of vacuole membrane fragmentation reveals regulation of vacuole size and number by TORC1.The TOR complex 1 is a direct target of Rho1 GTPase.Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.Efficient Tor signaling requires a functional class C Vps protein complex in Saccharomyces cerevisiaePhosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1.Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays.Target of rapamycin signaling mediates vacuolar fission caused by endoplasmic reticulum stress in Saccharomyces cerevisiae.Network-assisted target identification for haploinsufficiency and homozygous profiling screens.The TOR (target of rapamycin) signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeast Saccharomyces cerevisiae.Vesicular Trafficking Systems Impact TORC1-Controlled Transcriptional Programs in Saccharomyces cerevisiaeNutritional control via Tor signaling in Saccharomyces cerevisiae.Nuclear translocation of Gln3 in response to nutrient signals requires Golgi-to-endosome trafficking in Saccharomyces cerevisiaeProtein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.Signaling cascades as drug targets in model and pathogenic fungi.Endolysosomal membrane trafficking complexes drive nutrient-dependent TORC1 signaling to control cell growth in Saccharomyces cerevisiae
P2860
Q24548569-3818E22D-7350-4F3F-A6F4-D73E60B32110Q24644105-F85E894D-5D2B-4ADD-A6BD-BA6F1F2C7471Q26991692-94106210-3993-4784-8941-09E922647BF1Q27930185-2F0BD84C-F8A9-4DC4-AFFF-F38D96CA404BQ27930579-6D13B2B3-9697-417F-8FB9-FFA2FC3833A7Q27931396-5DD87675-5E6A-441A-9A55-F21EA2FC98C0Q27931595-8DCD2040-A037-4ABD-91CE-1C0FBEAC5DC2Q27932829-3ADDFEFB-ACF5-4447-AE42-266D271C0A1DQ27934220-32289FEC-BF10-4887-B832-C59774AF2DA1Q27934242-0D01BBED-FF11-469F-9FF9-44EF8CBC4311Q27936731-EC619AF2-0E32-4E6D-8C15-2F96CAEF0F59Q27939768-7EDB3BA6-727F-4A99-8B60-7D37D429DD19Q28343624-CE506B0A-A787-40FD-8978-C03F4BCE15D4Q28361576-98990114-37B1-4C42-A172-69906766EEF4Q28473456-19ED8E6A-4F07-4981-8326-9A2122F27334Q28579574-155A6164-03C3-4C6C-8332-1B02129D608EQ29620801-CCFE6B17-EFB8-439F-90AE-CBDC10CA4471Q30443949-6C6B4ADB-E7F9-4DB7-AD0E-A0B7652DC9C8Q30838871-4DD672BB-1525-4935-B0EB-A3B41438ADD2Q33651856-F40C7104-DDE1-4753-B26D-164B2AC7B547Q33836143-25F91478-4625-4FEA-8BA3-F23F457033D2Q33849166-4F80FE78-3C59-4E04-B5BA-631BFABEC206Q34689234-58928DBE-304F-45D8-A0CC-12900B49FD98Q35259428-061713C6-D29E-47E1-82BA-CC45EEC57FA5Q35319810-1021F407-5235-40F6-AC2E-06468ACB7EA9Q35790915-29F9807C-EBD6-459C-BBBC-A618AFE54520Q35906907-067DC5F3-BC1C-4418-BFAF-201811812C57Q35909879-CBBE0DAD-87AB-4C10-929A-2D17A04B9953Q35945677-2B12CE2B-4208-459A-809B-9B9EA01FF595Q36127992-C5DB5972-108D-490F-8629-2EA8284DD96FQ36347738-2E33365F-E145-4CBA-8A35-E095633385CEQ36368859-66A3B4A5-E1DF-4670-A3CB-9E395B453171Q36390732-B3A41075-42FD-4213-BD46-1A2AA6B9808EQ36468946-F939D295-3C50-4C0A-B966-8C89575BED47Q36648724-B84D9039-CEAB-40DD-A4FC-9BECAC38492EQ36671038-AFE9FB05-9AB9-424F-AF05-ADF313E29A80Q36734708-79FDECF4-78EA-451C-88C9-2EE70ACB8D94Q36901880-F1A6627E-DFD9-4BF5-ACED-EF338E8F41C8Q37230044-08791AD0-45FD-49A3-80CB-F6E2AF92AEA3Q37696384-B4B7BE96-C703-4BCD-A6FE-2C823F75955C
P2860
FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@ast
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@en
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@nl
type
label
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@ast
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@en
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@nl
prefLabel
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@ast
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@en
FKBP12-rapamycin target TOR2 i ...... dylinositol-4 kinase activity.
@nl
P2860
P1433
P1476
FKBP12-rapamycin target TOR2 i ...... idylinositol-4 kinase activity
@en
P2093
M E Cardenas
P2860
P304
P356
10.1002/J.1460-2075.1995.TB00277.X
P407
P577
1995-12-01T00:00:00Z